Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Hip fracture

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44347   clinical trials with a EudraCT protocol, of which   7375   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    149 result(s) found for: Hip fracture. Displaying page 5 of 8.
    « Previous 1  2  3  4  5  6  7  8  Next»
    EudraCT Number: 2006-000861-12 Sponsor Protocol Number: CZOL446H2409 Start Date*: 2007-01-29
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A one-year partial double-blinded, randomized, multi-center, multi-national study to assess the effects of combination therapy of annual zoledronic acid (5 mg) and daily subcutaneous teriparatide (...
    Medical condition: Postmenopausal women with severe osteoporosis
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: BE (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2015-004119-19 Sponsor Protocol Number: 2015-005-M Start Date*: 2016-04-25
    Sponsor Name:Reinier de Graaf Hospital
    Full Title: Femoral Nerve Blockage in Proximal Femoral Fractures in patients of 65 years of age or older, a Randomised Controlled Trial
    Medical condition: Pain in patients with a proximal femoral fracture.
    Disease:
    Population Age: Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-024393-19 Sponsor Protocol Number: 20101217 Start Date*: 2012-04-16
    Sponsor Name:Amgen, Inc.
    Full Title: A Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Denosumab Compared With Risedronate in Glucocorticoid-treated Individuals
    Medical condition: Glucocorticoid-induced osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    17.0 100000004859 10031287 Osteoporosis steroid-induced LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed) HU (Completed) NL (Completed) CZ (Completed) ES (Completed) PL (Completed) DE (Completed) DK (Completed) FR (Completed)
    Trial results: View results
    EudraCT Number: 2016-004698-42 Sponsor Protocol Number: 10102016 Start Date*: 2017-05-29
    Sponsor Name:
    Full Title: MORphine use in the Fascia Iliaca Compartment block with UltraSound guidance.
    Medical condition: Pain in proximal femur fractures
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2014-002587-33 Sponsor Protocol Number: MK-0822-018 Start Date*: 2015-01-22
    Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
    Full Title: An Open-Label 5-Year 2nd Extension to: A Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) to Reduce the Risk of Fracture in Osteopor...
    Medical condition: osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    17.1 10028395 - Musculoskeletal and connective tissue disorders 10031285 Osteoporosis postmenopausal PT
    Population Age: Elderly Gender: Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2020-000624-20 Sponsor Protocol Number: ILONA Start Date*: 2021-06-17
    Sponsor Name:Leipzig University
    Full Title: Core decompression versus core decompression followed by infusion of Iloprost in the treatment of non-traumatic avascular necrosis of the femoral head
    Medical condition: non-traumatic avascular necrosis of the femoral head (N-ANFH)
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004859 10003860 Avascular necrosis femoral head LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2010-020081-22 Sponsor Protocol Number: R&D 2185 Start Date*: 2011-02-08
    Sponsor Name:North Bristol NHS Trust
    Full Title: The administration of Parathyroid hormone affects functional recovery from pertrochanteric fractured neck of femur: A prospective randomised comparative pilot study with blinded objective functiona...
    Medical condition: Osteoporotic or low energy pertrochanteric hip fractures
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2011-005514-10 Sponsor Protocol Number: 0822-018 Start Date*: 2012-03-14
    Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
    Full Title: A 2nd Open-Label Extension for 5 Years to: The Placebo-Controlled 1st Extension to a Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) to Reduc...
    Medical condition: Postmenopausal Osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    17.1 10028395 - Musculoskeletal and connective tissue disorders 10031285 Osteoporosis postmenopausal PT
    Population Age: Elderly Gender: Female
    Trial protocol: LT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2011-004167-68 Sponsor Protocol Number: CHJTMP_01/2011 Start Date*: 2012-04-27
    Sponsor Name:MARIA TERESA PARRAS MALDONADO
    Full Title:
    Medical condition: 104 patients will be randomized to each of the two groups to apply TAP or femoral block, after which they were placed in lateral decubitus position and proceed to the performance of spinal anesthes...
    Disease:
    Population Age: Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-000434-35 Sponsor Protocol Number: 20120156 Start Date*: 2013-12-10
    Sponsor Name:Amgen, Inc
    Full Title: A Multicenter, Randomized, Multiple-dose Phase 3 Study to Evaluate the Noninferiority of Romosozumab at a 90 mg/mL Concentration Compared With a 70 mg/mL Concentration in Postmenopausal Women With...
    Medical condition: Postmenopausal osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    16.1 10028395 - Musculoskeletal and connective tissue disorders 10031285 Osteoporosis postmenopausal PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: PL (Completed) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2017-003512-40 Sponsor Protocol Number: 20150120 Start Date*: 2018-03-05
    Sponsor Name:Amgen Inc.
    Full Title: A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab via Autoinjector/Pen vs Heal...
    Medical condition: Postmenopausal osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    20.0 10028395 - Musculoskeletal and connective tissue disorders 10031285 Osteoporosis postmenopausal PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Completed) PL (Completed)
    Trial results: View results
    EudraCT Number: 2017-004220-30 Sponsor Protocol Number: BA058-05-019 Start Date*: 2018-07-25
    Sponsor Name:Radius Health, Inc.
    Full Title: A Randomized, Double blind, Placebo controlled, Phase 3 Multicenter Study to Evaluate the Safety and Efficacy of Abaloparatide SC for the Treatment of Men with Osteoporosis.
    Medical condition: Osteoporosis in men
    Disease: Version SOC Term Classification Code Term Level
    20.0 10028395 - Musculoskeletal and connective tissue disorders 10031282 Osteoporosis PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: PL (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2015-005529-37 Sponsor Protocol Number: 07.12.2015 Start Date*: 2016-02-29
    Sponsor Name:Bente Lomholt Langdahl
    Full Title: Treatment with zoledronic acid subsequent to denosumab in osteoporosis
    Medical condition: Osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004859 10031289 Osteoporosis, unspecified LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2012-005559-17 Sponsor Protocol Number: ACA-SPAI-12-07 Start Date*: 2013-04-22
    Sponsor Name:Rosa Herrera Castro
    Full Title: Hemodynamic consequences of isobaric levobupivacaine versus hyperbaric bupivacaine for spinal anesthesia in patients over 65 years, underwent hip surgery
    Medical condition: In patients 65 years or older undergoing hip surgery.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10042613 - Surgical and medical procedures 10051060 Hip surgery PT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-003113-26 Sponsor Protocol Number: CoLeBu Start Date*: 2018-05-09
    Sponsor Name:ROSA HERRERA CASTRO
    Full Title: Hemodynamic safety of isobaric levobupivacaine versus isobaric bupivacaine for spinal anesthesia in patients over 65 years, underwent hip surgery.
    Medical condition: In patients 65 years or older undergoing hip surgery.
    Disease: Version SOC Term Classification Code Term Level
    20.0 10042613 - Surgical and medical procedures 10051060 Hip surgery PT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-008257-30 Sponsor Protocol Number: 0822-042 Start Date*: 2009-03-31
    Sponsor Name:Merck & Co., Inc.
    Full Title: Estudio en fase IIa aleatorizado, doble ciego, controlado con placebo para evaluar los efectos de odanacatib (MK-0822) sobre la densidad mineral ósea (DMO) y la seguridad general en el tratamiento ...
    Medical condition: Osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10031285 Osteoporosis postmenopausal LLT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed) CZ (Completed) DE (Completed) BE (Completed) FR (Completed)
    Trial results: View results
    EudraCT Number: 2009-012929-11 Sponsor Protocol Number: PREOB-ON3 Start Date*: 2011-10-17
    Sponsor Name:Bone Therapeutics S.A.
    Full Title: Phase III, pivotal, multicentre, randomised, double-blind controlled Study to evaluate the Efficacy and Safety of Autologous Osteoblastic Cells (PREOB®) Implantation in Early Stage Non Traumatic Os...
    Medical condition: Osteonecrosis of the Femoral Head
    Disease: Version SOC Term Classification Code Term Level
    18.1 10028395 - Musculoskeletal and connective tissue disorders 10031264 Osteonecrosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Prematurely Ended) DE (Completed) GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2014-002492-29 Sponsor Protocol Number: 1928376455 Start Date*: 2014-10-10
    Sponsor Name:Department of anaesthesia and intensive care, Hvidovre Hospital
    Full Title: The effect of Single-Dose Glucocorticoid on Postoperative delirium among Elderly Hip Fracture Patientes: A Randomized Placebo Controlled Study
    Medical condition: Postoperative Delirium
    Disease: Version SOC Term Classification Code Term Level
    17.0 10037175 - Psychiatric disorders 10012218 Delirium PT
    17.0 10037175 - Psychiatric disorders 10012220 Delirium due to a general medical condition LLT
    17.0 10037175 - Psychiatric disorders 10000702 Acute delirium LLT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-002984-10 Sponsor Protocol Number: SMC021A-2303 Start Date*: 2005-08-23
    Sponsor Name:Nordic Bioscience
    Full Title: A randomized, double-blind, multi-center, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal woman taking calc...
    Medical condition: The trial is Phase III. The population will be healthy post-menopausal women who are between 55 and 85 years of age
    Disease: Version SOC Term Classification Code Term Level
    13.1 10028395 - Musculoskeletal and connective tissue disorders 10031282 Osteoporosis PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DK (Completed) EE (Completed) LT (Completed) GB (Completed) CZ (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2013-005551-32 Sponsor Protocol Number: 20110174 Start Date*: 2014-06-16
    Sponsor Name:Amgen, Inc.
    Full Title: A Multicenter, Randomized, Double blind, Placebo controlled Study to Compare the Efficacy and Safety of Romosozumab With Placebo in Men With Osteoporosis
    Medical condition: male osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    17.0 10028395 - Musculoskeletal and connective tissue disorders 10031282 Osteoporosis PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: CZ (Completed) BE (Completed) DK (Completed) PL (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    « Previous 1  2  3  4  5  6  7  8  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat Jul 05 03:16:50 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA